nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antithrombotic treatment for the preservation and enhancement of myocardial perfusion in chronic coronary artery disease
|
Leschke, M. |
|
1997 |
11 |
S1 |
p. 119-123 5 p. |
artikel |
2 |
Atherosclerosis, thrombosis and inflammation: a problem of linkage
|
Tracy, R.P. |
|
1997 |
11 |
S1 |
p. 137-141 5 p. |
artikel |
3 |
Bezafibrate following acute myocardial infarction: important findings from the bezafibrate coronary atherosclerosis intervention trial
|
Nilsson, J. |
|
1997 |
11 |
S1 |
p. 159-162 4 p. |
artikel |
4 |
Coronary artery disease and inflammation: reflection of underlying disease or repetitive ischemia
|
Liuzzo, G. |
|
1997 |
11 |
S1 |
p. 155-157 3 p. |
artikel |
5 |
C-reactive protein and cardiovascular disease
|
Haverkate, F. |
|
1997 |
11 |
S1 |
p. 133-134 2 p. |
artikel |
6 |
Endogenous fibrinolytic function and risks of future myocardial infarction and stroke: observations from the Physicians' Health Study
|
Ridker, P.M. |
|
1997 |
11 |
S1 |
p. 55-59 5 p. |
artikel |
7 |
Experiments on the risk factor role of fibrinogen
|
Born, G.V.R. |
|
1997 |
11 |
S1 |
p. 9-12 4 p. |
artikel |
8 |
Fibrinogen and atherosclerosis: a study in transgenic mice
|
Koopman, J. |
|
1997 |
11 |
S1 |
p. 19-21 3 p. |
artikel |
9 |
Fibrinogen mediates vasoactive effects in saphenous vein by an ICAM-1 dependent pathway
|
Hicks, R.C.J. |
|
1997 |
11 |
S1 |
p. 27-29 3 p. |
artikel |
10 |
Foreword
|
Koenig, W |
|
1997 |
11 |
S1 |
p. 1- 1 p. |
artikel |
11 |
Gene-environment interaction in the determination of plasma levels of fibrinogen
|
Humphries, S.E. |
|
1997 |
11 |
S1 |
p. 3-7 5 p. |
artikel |
12 |
Haemostatic system and arterial disease: future perspectives
|
Meade, T.W. |
|
1997 |
11 |
S1 |
p. 167-171 5 p. |
artikel |
13 |
Homocysteine, atherogenesis and thrombosis
|
Harpel, P.C. |
|
1997 |
11 |
S1 |
p. 77-80 4 p. |
artikel |
14 |
How does hyperfibrinogenemia lead to thrombosis?
|
McDonagh, J. |
|
1997 |
11 |
S1 |
p. 13-17 5 p. |
artikel |
15 |
How to detect activated coagulation
|
Bauer, K.A. |
|
1997 |
11 |
S1 |
p. 23-26 4 p. |
artikel |
16 |
Hyperfibrinogenemia and cardiovascular risk: possible strategies for intervention
|
Koenig, W. |
|
1997 |
11 |
S1 |
p. 41-46 6 p. |
artikel |
17 |
Hyperinsulinemia increases plasma activity of PAI-1 in vivo independently of an acute phase reaction
|
Nordt, T.K. |
|
1997 |
11 |
S1 |
p. 51-54 4 p. |
artikel |
18 |
Infection, hemostatic factors and cardiovascular disease
|
Khaw, K.T. |
|
1997 |
11 |
S1 |
p. 149-153 5 p. |
artikel |
19 |
Inflammation in atherosclerotic plaques: a clinically crucial event
|
van der Wal, A.C. |
|
1997 |
11 |
S1 |
p. 125-128 4 p. |
artikel |
20 |
Inflammation: the protein C pathway
|
Esmon, C.T. |
|
1997 |
11 |
S1 |
p. 143-148 6 p. |
artikel |
21 |
Inflammatory markers as predictors in unstable angina
|
de Maat, M.P.M. |
|
1997 |
11 |
S1 |
p. 135-136 2 p. |
artikel |
22 |
Lipoproteins and inflammation in atherosclerosis
|
Nilsson, J. |
|
1997 |
11 |
S1 |
p. 129-132 4 p. |
artikel |
23 |
Lp(a) lipoprotein and risk of atherosclerotic/thrombotic disease
|
Berg, K. |
|
1997 |
11 |
S1 |
p. 71-75 5 p. |
artikel |
24 |
Mechanisms for thrombolysis-induced increases in procoagulant and proinflammatory activity
|
Schaiff, W.T. |
|
1997 |
11 |
S1 |
p. 115-118 4 p. |
artikel |
25 |
Molecular markers of hemostasis and fibrinolysis and inhibitor levels in unstable angina pectoris
|
Hoffmeister, H.M. |
|
1997 |
11 |
S1 |
p. 61-65 5 p. |
artikel |
26 |
New antithrombotic agents: an overview
|
Windstetter, U. |
|
1997 |
11 |
S1 |
p. 85-96 12 p. |
artikel |
27 |
New developments in thrombolytic therapy
|
Bode, C. |
|
1997 |
11 |
S1 |
p. 109-114 6 p. |
artikel |
28 |
Pathophysiology of acute ischemic syndromes: recent progress
|
Kristensen, S.D. |
|
1997 |
11 |
S1 |
p. 105-108 4 p. |
artikel |
29 |
Plasma fibrinogen and wall thickness in carotid and femoral arteries: findings from the KIHD study
|
Salonen, J.T. |
|
1997 |
11 |
S1 |
p. 35-40 6 p. |
artikel |
30 |
Recent advances in hemostatic risk factors and cardiovascular diseases
|
Wu, K.K. |
|
1997 |
11 |
S1 |
p. 31-34 4 p. |
artikel |
31 |
Some interactions between the haemostatic system and lipids
|
Miller, G.J. |
|
1997 |
11 |
S1 |
p. 67-69 3 p. |
artikel |
32 |
Subject index
|
|
|
1997 |
11 |
S1 |
p. 173-176 4 p. |
artikel |
33 |
The role of platelets in the early and late vascular responses initiated by mechanical vascular injury
|
Harker, L.A. |
|
1997 |
11 |
S1 |
p. 97-103 7 p. |
artikel |
34 |
Urinary 8-EPI PGF2α: an index of oxidant stress in vivo
|
Reilly, M.P. |
|
1997 |
11 |
S1 |
p. 81-84 4 p. |
artikel |
35 |
Variables of the fibrinolytic system: risk indicators for CHD
|
Juhan-Vague, I. |
|
1997 |
11 |
S1 |
p. 47-49 3 p. |
artikel |
36 |
Which haemostatic factors should be measured in clinical practice for the prediction of coronary risk?
|
van de Loo, J.C.W. |
|
1997 |
11 |
S1 |
p. 163-165 3 p. |
artikel |